Cayman JNJ-10181457 (hydrochloride)

JNJ-10181457 is an antagonist of histamine H₃ receptors (K_is = 1.17 and 7.08 nM for human and rat receptors, respectively).¹ It increases extracellular norepinephrine and acetylcholine levels in the frontal cortex of rats when administered subcutaneously at a dose of 10 mg/kg. JNJ-10181457 (1.25-10 mg/kg, p.o.) reduces the number of cataplectic attacks and time spent in cataplexy in familial narcoleptic Dobermans. In mice, JNJ-10181457 (10 mg/kg) decreases the time spent in the open areas of the elevated zero maze, as well as increases locomotor activity in an open field test.² It also inhibits LPS-induced increases in time spent immobile in the tail suspension test in mice.³

WARNING This product is not for human or veterinary use.